FDA-Inspected Site

Niagara Pharmaceuticals, Inc

7 FDA inspections are on record for Niagara Pharmaceuticals, Inc in Dundas, Canada.

483· Form 483 issued

Dundas, Canada · Last updated July 10, 2026

Overview

  • 7 FDA inspections are on record.
  • 4 inspections produced a Form 483.
  • The most recent recorded inspection date is 2022-04-25.

At a glance

Inspections

7

Form 483s

4

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
18 Apr 2022 – 25 Apr 2022Human Drugs483View 483 →
30 Jan 2020 – 7 Feb 2020Human Drugs483View 483 →
14 Sep 2017 – 18 Sep 2017Human DrugsClean
9 May 2016 – 16 May 2016Human Drugs483View 483 →
12 May 2014 – 14 May 2014Human DrugsClean
8 Sep 2010Not recorded483View 483 →
13 Sep 2006Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

25 Apr 2022
21 CFR 211.100(a)

Approval and review of procedures

Cited by Alan P Kurtzberg

25 Apr 2022
21 CFR 211.103

Actual vs. theoretical yields not determined

Cited by Alan P Kurtzberg

25 Apr 2022
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Alan P Kurtzberg

25 Apr 2022
21 CFR 211.84(b)

Representative Samples Criteria

Cited by Alan P Kurtzberg

7 Feb 2020
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Jay T Wong

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.103Cited across public-safe Form 483 observations1x
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.165(a)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.80(d)Cited across public-safe Form 483 observations1x
21 CFR 211.84(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Niagara Pharmaceuticals, Inc's 4 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat